Blog

Dr. Succaria on Combination Immunotherapy in Head and Neck Cancer – OncLive

Dr. Succaria on Combination Immunotherapy in Head and Neck Cancer
OncLive
In a study of the tumor microenvironment of head and neck squamous cell carcinoma (SCCHN), investigators were interested in the effects of combination immunotherapy. Monotherapy with checkpoint inhibition has previously shown efficacy in head and …

2018-05-25 NEWS
About Michael Zand

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.